Proton Pump Inhibitors and Cancer Risk - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

  • By

  • Kathryn Wighton

  • February 19, 2026

  • 3 min

Share

Original Source(s)

Proton Pump Inhibitors and Cancer Risk

  • by Kathryn Wighton

  • February 19, 2026

Related Content

Editorial: Metabolite-induced metabolic reprogramming in the immune system

Mechanistic remodeling and immunoregulatory functions of the B cell–humoral immunity axis in inflammatory bowel disease

Fecal microbiota transplantation in ulcerative colitis: mucosal immune mechanisms and precision microbiota therapy